SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

26 May 2026 Evaluate
The Revenue for the quarter ended  March 2026 of Rs. 442.33 millions grew by 17.22 % from Rs. 377.36 millions.Net profit declined -9.22% to Rs. 108.91 millions from Rs. 119.97 millions.The company reported a good operating profit of 202.81 millions compared to 173.86 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 442.33 377.36 17.22 1658.23 1508.00 9.96 1658.23 1508.00 9.96
Other Income 9.21 13.48 -31.68 24.28 24.32 -0.16 24.28 24.32 -0.16
PBIDT 202.81 173.86 16.65 779.58 712.76 9.37 779.58 712.76 9.37
Interest 19.06 0.71 2584.51 29.49 3.64 710.16 29.49 3.64 710.16
PBDT 183.75 173.15 6.12 750.09 709.12 5.78 750.09 709.12 5.78
Depreciation 40.38 12.28 228.83 129.19 53.75 140.35 129.19 53.75 140.35
PBT 143.37 160.87 -10.88 620.90 655.37 -5.26 620.90 655.37 -5.26
TAX 34.46 40.90 -15.75 154.08 167.66 -8.10 154.08 167.66 -8.10
Deferred Tax 10.70 2.32 361.21 46.22 2.80 1550.71 46.22 2.80 1550.71
PAT 108.91 119.97 -9.22 466.82 487.71 -4.28 466.82 487.71 -4.28
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 108.97 0.00
PBIDTM(%) 45.85 46.07 -0.48 47.01 47.27 -0.53 47.01 47.27 -0.53

Guj. Themis Biosyn Share Price

405.10 -6.45 (-1.57%)
05-Jun-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1789.25
Dr. Reddys Lab 1274.20
Cipla 1387.50
Zydus Lifesciences 1088.05
Lupin 2264.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×